This article has been updated from a previous version to include comments made by CombiMatrix CEO Mark McDonough in an earnings call.

NEW YORK (GenomeWeb) - CombiMatrix reported today that its third quarter revenues rose 29 percent year over year, supported by a 14 percent increase in test volume across the company's menu of assays.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.